SARS-CoV-2 Infection and Severity in Patients with Hematologic Malignancies: A Systematic Review.

SeyedAhmad SeyedAlinaghi,Amirali Karimi,Pegah Mirzapour,Roghayeh Salmani,Armin Razi,Hengameh Mojdeganlou,Paniz Mojdeganlou,Mohammad Qodrati, Reyhaneh Jashaninejad,Parinaz Paranjkhoo,Omid Dadras,Besharat Zarezadeh,Amir Masoud Afsahi,Arian Afzalian,Sanaz Varshochi,Esmaeil Mehraeen,Ghazaleh Afsahi

Infectious disorders drug targets（2023）

引用 0|浏览13

暂无评分

摘要

It appeared that individuals with hematologic malignancies are more vulnerable to COVID-19 infection and they experience more severe disease with higher mortality rates. The presence of other comorbidities could also deteriorate this situation. Further Investigation is recommended to evaluate the outcome of COVID-19 infection in different subtypes of hematologic malignancies.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要